General Hospital Of Shenyang Military Region
Clinical trials sponsored by General Hospital Of Shenyang Military Region, explained in plain language.
-
Second chance: new stroke treatment could save more brain tissue
Disease control Not yet recruitingThis study tests whether giving an extra dose of the clot-busting drug prourokinase can help stroke patients with medium or large blocked brain arteries who don't improve after the first dose. About 122 adults will be enrolled within 4.5 hours of stroke onset. The goal is to see …
Phase: PHASE2 • Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Which drug saves kidneys in liver bleeding emergencies?
Disease control Not yet recruitingThis study compares two medications, terlipressin and somatostatin, in 64 adults with liver cirrhosis who have both acute gastrointestinal bleeding and acute kidney injury. The goal is to see which drug better reverses the kidney damage. Participants will be randomly assigned to …
Phase: NA • Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated May 11, 2026 20:53 UTC